Live Breaking News & Updates on Impel Neuropharma Inc|Page 6
Stay updated with breaking news from Impel neuropharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"The Buzz" Show: Impel NeuroPharma, Inc. (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
This analyst raised price target on Impel NeuroPharma by more than 50% invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.
North American Morning Briefing: Weak Chinese -3- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Impel NeuroPharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.